Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Věra Čertíková, Chábová"'
Autor:
Oskar Zakiyanov, Yaprak Ḉaḡlar, Romana Ryšavá, Eva Jančová, Dita Maixnerová, Doubravka Frausová, Tomáš Indra, Eva Honsová, Vítězslav Kříha, Ivan Rychlík, Vladimír Tesař, Věra Čertíková Chábová
Publikováno v:
Kidney & Blood Pressure Research, Pp 1-1 (2023)
Introduction: Acute tubulointerstitial nephritis (ATIN) is a well-recognized cause of acute kidney injury (AKI) due to the tubulointerstitial inflammation. The aim of this study was to explore the clinical features, outcomes, and responses to cortico
Externí odkaz:
https://doaj.org/article/4aee662669b341df809e7d24405cd3b1
Autor:
Zuzana Honetschlagerová, Petra Škaroupková, Soňa Kikerlová, Zuzana Husková, Hana Maxová, Vojtěch Melenovský, Elzbieta Kompanowska-Jezierska, Janusz Sadowski, Olga Gawrys, Petr Kujal, Luděk Červenka, Věra Čertíková Chábová
Publikováno v:
Clinical and Experimental Hypertension, Vol 43, Iss 6, Pp 522-535 (2021)
Background: The coincidence of congestive heart failure (CHF) and chronic kidney disease (CKD) results in poor survival rate. The aim of the study was to examine if renal denervation (RDN) would improve the survival rate in CHF induced by creation of
Externí odkaz:
https://doaj.org/article/285e238d66e241cf8f0f478fd8e52e22
Autor:
Věra Čertíková Chábová, Petr Kujal, Zdeňka Vaňourková, Petra Škaroupková, Janusz Sadowski, Elzbieta Kompanowska-Jezierska, Vladimír Tesař, Bruce Hammock, John Imig, Hana Maxová, Luděk Červenka, Ivana Vaněčková
Publikováno v:
Kidney & Blood Pressure Research, Vol 44, Iss 6, Pp 1493-1505 (2019)
Introduction: Previous studies in Ren-2 transgenic hypertensive rats (TGR) after 5/6 renal ablation (5/6 NX) have shown that besides pharmacological blockade of the renin-angiotensin system (RAS) also increasing kidney tissue epoxyeicosatrienoic acid
Externí odkaz:
https://doaj.org/article/e825f8319c354c929117bd918f0dbf1d
Autor:
Věra Čertíková Chábová, Petr Kujal, Petra Škaroupková, Zdeňka Varňourková, Šárka Vacková, Zuzana Husková, Soňa Kikerlová, Janusz Sadowski, Elzbieta Kompanowska-Jezierska, Iwona Baranowska, Sung Hee Hwang, Bruce D. Hammock, John D. Imig, Vladimír Tesař, Ludek Červenka
Publikováno v:
Kidney & Blood Pressure Research, Vol 43, Iss 2, Pp 329-349 (2018)
Background/Aims: We found recently that increasing renal epoxyeicosatrienoic acids (EETs) levels by blocking soluble epoxide hydrolase (sEH), an enzyme responsible for EETs degradation, shows renoprotective actions and retards the progression of chro
Externí odkaz:
https://doaj.org/article/11b36c3fd958496eb6b6610466ba58ff
Autor:
Lenka Sedláková, Věra Čertíková Chábová, Šárka Doleželová, Petra Škaroupková, Libor Kopkan, Zuzana Husková, Lenka Červenková, Soňa Kikerlová, Ivana Vaněčková, Janusz Sadowski, Elzbieta Kompanowska-Jezierska, Petr Kujal, Herbert J. Kramer, Luděk Červenka
Publikováno v:
Clinical and Experimental Hypertension, Vol 39, Iss 2, Pp 183-195 (2017)
Background: Early addition of endothelin (ET) type A (ETA) receptor blockade to complex renin–angiotensin system (RAS) blockade has previously been shown to provide better renoprotection against progression of chronic kidney disease (CKD) in Ren-2
Externí odkaz:
https://doaj.org/article/069801b85c634eb1ad2d34b86397326b
Autor:
Vojtěch Melenovský, Elzbieta Kompanowska-Jezierska, Věra Čertíková Chábová, Zuzana Husková, H. Maxová, Janusz Sadowski, Olga Gawrys, Petra Škaroupková, Zuzana Honetschlägerová, Petr Kujal, Luděk Červenka, Soňa Kikerlová
Publikováno v:
Clinical and Experimental Hypertension. 43:522-535
Background: The coincidence of congestive heart failure (CHF) and chronic kidney disease (CKD) results in poor survival rate. The aim of the study was to examine if renal denervation (RDN) would improve the survival rate in CHF induced by creation of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d99b60f1cb39f53a41d1634c68b0b2a6
https://doi.org/10.1080/10641963.2021.1907398
https://doi.org/10.1080/10641963.2021.1907398
Autor:
Věra Čertíková Chábová
Publikováno v:
Klinická farmakologie a farmacie. 33:35-38
Inhibitory angiotenzin konvertujiciho enzymu (ACE) se kromě hypertenze uplatňuji v lecbě kardialniho selhani a snižovani protenurie u onemocněni ledvin. System renin‑angiotenzin‑aldosteron je vsak velmi komplexni a dnes jsou k dispozici dals
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::76b5b9078f3f4d4f1babe261f843df89
https://doi.org/10.36290/far.2019.030
https://doi.org/10.36290/far.2019.030
Autor:
Bruce D. Hammock, Petr Kujal, H. Maxová, Vladimír Tesař, John D. Imig, Ivana Vaněčková, Věra Čertíková Chábová, Elzbieta Kompanowska-Jezierska, Luděk Červenka, Janusz Sadowski, Zdeňka Vaňourková, Petra Škaroupková
Publikováno v:
Kidney & Blood Pressure Research, Vol 44, Iss 6, Pp 1493-1505 (2019)
Kidney & blood pressure research, vol 44, iss 6
Kidney & blood pressure research, vol 44, iss 6
Introduction: Previous studies in Ren-2 transgenic hypertensive rats (TGR) after 5/6 renal ablation (5/6 NX) have shown that besides pharmacological blockade of the renin-angiotensin system (RAS) also increasing kidney tissue epoxyeicosatrienoic acid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7768bfb7507a7f72f40cc177300989da
https://www.karger.com/Article/FullText/504137
https://www.karger.com/Article/FullText/504137
Autor:
Šárka, Jíchová, Olga, Gawryś, Elżbieta, Kompanowska-Jezierska, Janusz, Sadowski, Vojtěch, Melenovský, Lenka, Hošková, Luděk, Červenka, Petr, Kala, Josef, Veselka, Věra, Čertíková Chábová
Publikováno v:
International Journal of Molecular Sciences
The aim of the present study was to perform kidney messenger ribonucleic acid (mRNA) analysis in normotensive, Hannover Sprague–Dawley (HanSD) rats and hypertensive, Ren-2 renin transgenic rats (TGR) after doxorubicin-induced heart failure (HF) wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d1631676dbd89bac8d565d6279321c31
https://pubmed.ncbi.nlm.nih.gov/34445179
https://pubmed.ncbi.nlm.nih.gov/34445179
Publikováno v:
International Journal of Molecular Sciences. 23:2812
Sodium glucose transporter type 2 (SGLT2) molecules are found in proximal tubules of the kidney, and perhaps in the brain or intestine, but rarely in any other tissue. However, their inhibitors, intended to improve diabetes compensation, have many mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77b7c3308663f73fbfe3e92f3e5f7019
https://doi.org/10.3390/ijms23052812
https://doi.org/10.3390/ijms23052812